Yao Wang
Ningbo University(CN)Zhejiang Chinese Medical University(CN)The University of Sydney(AU)Fujian Medical University(CN)Xi'an University of Architecture and Technology(CN)Harbin Medical University(CN)China Pharmaceutical University(CN)Zunyi Medical University(CN)Nantong University(CN)Ruijin Hospital(CN)Guangzhou Institutes of Biomedicine and Health(CN)Tianjin Medical University Cancer Institute and Hospital(CN)Chinese PLA General Hospital(CN)Affiliated Hospital of Nantong University(CN)Mudanjiang Medical University(CN)Shanghai University of Traditional Chinese Medicine(CN)Second Affiliated Hospital of Harbin Medical University(CN)Shanghai Traditional Chinese Medicine Hospital(CN)Northern Jiangsu People's Hospital(CN)Tang Du Hospital(CN)People's Hospital of Yangzhong(CN)Yangzhou University(CN)Shaanxi Normal University(CN)Wuyi University(CN)
Publications by Year
Research Areas
CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells(2020)1,271 cited
- → The Roles of Growth Factors in Tendon and Ligament Healing(2003)938 cited
- → Treatment of CD33-directed Chimeric Antigen Receptor-modified T Cells in One Patient With Relapsed and Refractory Acute Myeloid Leukemia(2014)408 cited
- → Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial(2016)325 cited
- → CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial(2018)323 cited
- → Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia(2020)315 cited